AbbVie · 20 hours ago
2026 Statistics Intern (PhD)
Florham Park, NJ
Internship
Onsite
Intern
$59K/yr - $100K/yr
Start in 2026 SummerAbbVie is a pharmaceutical company focused on discovering and delivering innovative medicines and solutions. The Statistics Intern will support the Statistical Sciences organization by conducting research on statistical topics and providing analytical support for various projects in the pharmaceutical industry.
BiotechnologyFinancial ServicesHealth CareMedicalPharmaceuticalVenture Capital
Responsibilities
Conduct research on one or more statistical topics
Support other projects as needed
Present project/assignment results and learnings to department leadership and the broader Stats organization
Qualification
Required
Currently enrolled in university, pursuing a PhD in statistics, biostatistics, bioinformatics, biomedical engineering, data science, or other closely related field
Must be enrolled in university for at least one semester following the internship
Must have completed at least two full years of PhD study prior to the start of the internship
Track record of accomplishment
Preferred
Expected graduation date between December 2026 – June 2027
Benefits
Competitive pay
Relocation support for eligible students
Select wellness benefits and paid holiday / sick time
Company
AbbVie
AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics. It is a sub-organization of AbbVie.
Founded in 2013
10001+ employees
H1B Sponsorship
AbbVie has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (273)
2024 (190)
2023 (225)
2022 (284)
2021 (186)
2020 (186)
Funding
Current Stage
Public CompanyTotal Funding
$15B2024-02-27Post Ipo Debt· $15B
2023-03-08Post Ipo Equity· $0.25M
2012-12-20IPO
Leadership Team
Robert Michael
Chairman of the Board and Chief Executive Officer
Micah Bregman
Vice President, Global Strategy and Pipeline, Allergan Aesthetics
Recent News
2025-12-31
Company data provided by crunchbase